Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 26 Leukemia, Myeloid, Acute 24 Recurrence 12 Sarcoma 7 Lymphoma, Large B-Cell, Diffuse 6 Neoplasm Metastasis 5 Neurofibrosarcoma 4 Neoplasms, Plasma Cell 4 Lymphoma 4 Triple Negative Breast Neoplasms 3 Ovarian Neoplasms 3 Myelodysplastic Syndromes 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma, B-Cell 3 Thymoma 2 Rhabdoid Tumor 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Melanoma 2 Lymphoma, Mantle-Cell 2 Liposarcoma 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Biphenotypic, Acute 2 Leukemia 2 Congenital Abnormalities 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Breast Neoplasms 2 Wilms Tumor 1

Interventions

Sunitinib 4 Cyclophosphamide 4 Capecitabine 4 Bevacizumab 4 pazopanib 3 Topotecan 3 Paclitaxel 3 Docetaxel 3 Carboplatin 3 temsirolimus 2 liposomal doxorubicin 2 fludarabine 2 Sorafenib 2 Panobinostat 2 NVP-BKM120 2 Lapatinib 2 Irinotecan 2 Immune Checkpoint Inhibitors 2 Gemcitabine 2 Everolimus 2 Erlotinib Hydrochloride 2 Doxorubicin 2 Bortezomib 2 vadimezan 1 spartalizumab 1 somatostatin receptor 2 1 selinexor 1 selicrelumab 1 perifosine 1 pegylated granulocyte colony-stimulating factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Solid Tumors × selinexor × Clear all

NCT02078349 2020-09-10

Phase I Study of KPT330 in Asian Patients

National University Hospital, Singapore

Phase 1 Completed

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡